Literature DB >> 6247368

Seroepidemiology of rotavirus infection in rural Bangladesh.

D A Sack, R H Gilman, A Z Kapikian, K M Aziz.   

Abstract

A prospective seroepidemiological study of rotavirus infection was performed in children in a village in rural Bangladesh. Ninety-three percent of the children had detectable antibodies during the study, and there were 66 significant rises in titer occurring in 57 of the 85 children. Antibody titer rises occurred in older children and younger children with equal frequency. Nine children (11%) had evidence of multiple infections during the 16-month period. Winter infections were most frequent, although one summer (monsoon) season was also associated with a large cluster. Subjects with high titers (greater than 1:8) of antibody less frequently developed a titer rise than did subjects with lower titers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247368      PMCID: PMC273448          DOI: 10.1128/jcm.11.5.530-532.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Distribution and titres of rotavirus antibodies in different age groups.

Authors:  M M Elias
Journal:  J Hyg (Lond)       Date:  1977-12

2.  Age distribution of antibody to reovirus-like agent in children in Taiwan.

Authors:  P Echeverria; N R Blacklow; M T Ho; G Cukor; R P Beasley
Journal:  J Pediatr       Date:  1977-12       Impact factor: 4.406

3.  Agents affecting health of mother and child in a rural area of Kenya. XI. Antibodies against rotavirus in sera from children living in the Machakos District of Kenya.

Authors:  D Metselaar; D A Sack; A Z Kapikian; A S Muller
Journal:  Trop Geogr Med       Date:  1978-12

4.  Recurrent rotavirus gastroenteritis.

Authors:  J Fonteyne; G Zissis; J P Lambert
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

5.  Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh.

Authors:  R W Ryder; D A Sack; A Z Kapikian; J C McLaughlin; J Chakraborty; A S Mizanur Rahman; M H Merson; J G Wells
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

6.  Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children.

Authors:  A Z Kapikian; H W Kim; R G Wyatt; W L Cline; J O Arrobio; C D Brandt; W J Rodriguez; D A Sack; R M Chanock; R H Parrott
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

7.  Aetiology of acute gastroenteritis in infancy and early childhood in southern India.

Authors:  P P Maiya; S M Pereira; M Mathan; P Bhat; M J Albert; S J Baker
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

8.  Antigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritis.

Authors:  A Z Kapikian; W L Cline; H W Kim; A R Kalica; R G Wyatt; D H Vankirk; R M Chanock; H D James; A L Vaughn
Journal:  Proc Soc Exp Biol Med       Date:  1976-09
  8 in total
  4 in total

Review 1.  Mucosal defense against enteric pathogens.

Authors:  S C Sanyal
Journal:  Indian J Pediatr       Date:  1983 May-Jun       Impact factor: 1.967

2.  Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans.

Authors:  M Yasukawa; O Nakagomi; Y Kobayashi
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

3.  Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador.

Authors:  Ben Lopman; Yosselin Vicuña; Fabian Salazar; Nely Broncano; Matthew D Esona; Carlos Sandoval; Nicole Gregoricus; Michael D Bowen; Daniel Payne; Martiza Vaca; Martha Chico; Umesh Parashar; Philip J Cooper
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

4.  Rotavirus infection in calves in Bangladesh.

Authors:  S A Selim; K M Aziz; A J Sarker; H Rahman
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.